Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|December 14, 2007
The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myelomaRobert P Evans, Claudia Naber, Tara Steffler, et al.
The Journal of Molecular Diagnostics : JMD|June 27, 2007
Microfluidic chips for detecting the t(4;14) translocation and monitoring disease during treatment using reverse transcriptase-polymerase chain reaction analysis of IgH-MMSET hybrid transcriptsJaron VanDijken, Govind V Kaigala, Jana Lauzon, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCsBrian J Taylor, Tony Reiman, Julie A Pittman, et al.
Plos One|June 2, 2015
Skeletal muscle radio-density is an independent predictor of response and outcomes in follicular lymphoma treated with chemoimmunotherapyMichael P Chu, Jessica Lieffers, Sunita Ghosh, et al.
British Journal of Haematology|November 28, 2008
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access programJoseph R Mikhael, Andrew R Belch, H Miles Prince, et al.
Plos One|June 1, 2013
Frequent occurrence of highly expanded but unrelated B-cell clones in patients with multiple myelomaJitra Kriangkum, Sarah N Motz, Carina S Debes Marun, et al.
Leukemia & Lymphoma|October 23, 2002
Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's diseaseTony Reiman, Marilyn L Clarke, Laith Dabbagh, et al.
Plos One|June 21, 2014
Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancerHemalatha Kuppusamy, Helga M Ogmundsdottir, Eva Baigorri, et al.
Blood|April 24, 2004
RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myelomaChristopher A Maxwell, Erik Rasmussen, Fenghuang Zhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplantA Keith Stewart, Christine I Chen, Kang Howson-Jan, et al.
Pageof 6